Next 10 |
home / stock / cme / cme articles
Trendless Markets are an Investor's Worst Nightmare Over my two-decade active investing career, I have learned valuable lessons by studying my ...
CME Gr (NASDAQ:CME) has outperformed the market over the past 20 years by 3.72% on an annualized basis producing an average annual return of 11.41%...
Markets are preparing for the coming interest rate cycle proposed by the Federal Reserve (the Fed). Though most sectors have priced in this potenti...
The momentum trade has been exhausted by the large-capitalization stocks in the market, especially those in the technology sector, as names like Nv...
Every cycle brings new opportunities; now that the Federal Reserve (the Fed) is looking to cut interest rates in 2024, the market could be getting ...
CME Gr (NASDAQ:CME) has outperformed the market over the past 20 years by 4.17% on an annualized basis producing an average annual return of 12.02%...
The United States economy just entered into a new cycle. Because markets shift according to their six to nine-month expectations, three stocks in t...
CHICAGO, March 25, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that open interest in Copper op...
You can think of the S&P 500 and the NASDAQ 100 indexes as the sun that gets the rest of the stock market booming or busting. As these have bee...
News, Short Squeeze, Breakout and More Instantly...
2024-04-25 06:00:07 ET Benjamin Budish from Barclays issued a price target of $228.00 for CME on 2024-04-25 05:00:00. The adjusted price target was set to $228.00. At the time of the announcement, CME was trading at $212.59. The overall price target consensus is at $218....
Pegasystems Inc. (PEGA) is expected to report $0.2 for Q1 2024 Masco Corporation (MAS) is expected to report $0.87 for Q1 2024 Avery Dennison Corporation (AVY) is expected to report $2.15 for Q1 2024 Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A...
Trendless Markets are an Investor's Worst Nightmare Over my two-decade active investing career, I have learned valuable lessons by studying my ...